| Net income | 76.11M |
| Depreciation and amortization | 27.78M |
| Provision for warranties | |
| Deferred income taxes | |
| Foreign currency revaluation | |
| Stock-based compensation costs | 12.05M |
| Tax benefit from stock options exercised | |
| Impairment of long lived asset | |
| Write-down of cost-method investments | |
| Accounts receivable, net | |
| Inventories | -28.07M |
| Prepaid expenses and other current assets | -19.12M |
| Accounts payable, accrued expenses, income taxes and other liabilities | -18.71M |
| Net cash provided by operating activities | |
| Purchases of property, plant and equipment | -14.56M |
| Proceeds from sale of maturing investment securities | |
| Patent registration costs | -2.47M |
| Proceeds from disposal of business assets and contracts | |
| Business acquisitions, net of cash acquired | -3.09M |
| Purchases of cost-method investments | -2.76M |
| Purchases of foreign currency contracts | |
| Proceeds from exercise of foreign currency contracts | |
| Net cash used in investing activities | |
| Proceeds from issuance of common stock, net | 6.33M |
| Repayment of borrowings | -25M |
| Proceeds from borrowings, net of borrowing costs | 25M |
| Tax benefit from stock option exercises | |
| Purchases of treasury stock | 0 |
| Net cash (used in) provided by financing activities | |
| Effect of exchange rate changes on cash | 17.2M |
| Net increase in cash and cash equivalents | 50.22M |
| Cash and cash equivalents at beginning of the year | 731.43M |
| Cash and cash equivalents at end of the year | 781.66M |
| Income taxes paid, net of refunds | |
| Interest paid, net of capitalized interest | 6.4M |
| Fair value of assets acquired in acquisitions, excluding cash | |
| Liabilities assumed | |
| Goodwill on acquisition | 457K |
| Fair value of contingent consideration | |
| Total purchase price | |
| Less: Deposit paid in previous period | |
| Cash paid for acquisition | 3.09M |